The phantom ligand effect: Allosteric control of transcription by the retinoid X receptor

被引:109
作者
Schulman, IG
Li, C
Schwabe, JWR
Evans, RM
机构
[1] SALK INST BIOL SCI, LA JOLLA, CA 92037 USA
[2] UNIV CALIF SAN DIEGO, HOWARD HUGHES MED INST, LA JOLLA, CA 92037 USA
关键词
transcription; RXR; phantom ligand effect; RAR;
D O I
10.1101/gad.11.3.299
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Regulation of gene expression via allosteric control of transcription is one of the fundamental concepts of molecular biology. Studies in prokaryotes have illustrated that binding of small molecules or ligands to sequence-specific transcription factors can produce conformational changes at a distance from the binding site. These ligand-induced changes can dramatically alter the DNA binding and/or trans-activation abilities of the target transcription factors. In this work, analysis of trans-activation by members of the steroid and thyroid hormone receptor superfamily identifies a unique form of allosteric control, the phantom ligand effect. Binding of a novel ligand (LG100754) to one submit (RXR) of a heterodimeric transcription factor results in a linked conformational change in the second noncovalently bound subunit of the heterodimer (RAR). This conformational change results in both the dissociation of corepressors and association of coactivators in a fashion mediated by the activation function of the non-liganded subunit. Without occupying the RAR hormone binding pocket, binding of LG100754 to RXR mimics exactly the effects observed when hormone is bound to RAR. Thus, L6100754 behaves as a phantom ligand.
引用
收藏
页码:299 / 308
页数:10
相关论文
共 41 条
[1]  
ALLEGRETTO EA, 1993, J BIOL CHEM, V268, P26625
[2]   RETINOIC ACID RECEPTORS AND RETINOID X-RECEPTORS - INTERACTIONS WITH ENDOGENOUS RETINOIC ACIDS [J].
ALLENBY, G ;
BOCQUEL, MT ;
SAUNDERS, M ;
KAZMER, S ;
SPECK, J ;
ROSENBERGER, M ;
LOVEY, A ;
KASTNER, P ;
GRIPPO, JF ;
CHAMBON, P ;
LEVIN, AA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (01) :30-34
[3]   A TRANSFERABLE SILENCING DOMAIN IS PRESENT IN THE THYROID-HORMONE RECEPTOR, IN THE V-ERBA ONCOGENE PRODUCT AND IN THE RETINOIC ACID RECEPTOR [J].
BANIAHMAD, A ;
KOHNE, AC ;
RENKAWITZ, R .
EMBO JOURNAL, 1992, 11 (03) :1015-1023
[4]   Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1 [J].
Baur, EV ;
Zechel, C ;
Heery, D ;
Heine, MJS ;
Garnier, JM ;
Vivat, V ;
LeDouarin, B ;
Gronemeyer, H ;
Chambon, P ;
Losson, R .
EMBO JOURNAL, 1996, 15 (01) :110-124
[5]   CRYSTAL-STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE HUMAN NUCLEAR RECEPTOR RXR-ALPHA [J].
BOURGUET, W ;
RUFF, M ;
CHAMBON, P ;
GRONEMEYER, H ;
MORAS, D .
NATURE, 1995, 375 (6530) :377-382
[6]   INTERACTION OF PROTEINS WITH TRANSCRIPTIONALLY ACTIVE ESTROGEN-RECEPTORS [J].
CAVAILLES, V ;
DAUVOIS, S ;
DANIELIAN, PS ;
PARKER, MG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (21) :10009-10013
[7]   Role of CBP/P300 in nuclear receptor signalling [J].
Chakravarti, D ;
LaMorte, VJ ;
Nelson, MC ;
Nakajima, T ;
Schulman, IG ;
Juguilon, H ;
Montminy, M ;
Evans, RM .
NATURE, 1996, 383 (6595) :99-103
[8]   SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers [J].
Chen, JD ;
Umesono, K ;
Evans, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) :7567-7571
[9]   A TRANSCRIPTIONAL CO-REPRESSOR THAT INTERACTS WITH NUCLEAR HORMONE RECEPTORS [J].
CHEN, JD ;
EVANS, RM .
NATURE, 1995, 377 (6548) :454-457
[10]  
Claret FX, 1996, MOL CELL BIOL, V16, P219